Photodynamic therapy (PDT) has aroused great research interest in recent years owing to its
high spatiotemporal selectivity, minimal invasiveness, and low systemic toxicity. However …

Cancer has emerged over the last decades as one of the deadliest diseases in the world.
Among the most commonly used techniques (ie surgery, immunotherapy, radiotherapy or …

Tumor hypoxia seriously impairs the therapeutic outcomes of type II photodynamic therapy
(PDT), which is highly dependent upon tissue oxygen concentration. Herein, a facile strategy …

Advanced treatments based on immune system manipulation, gene transcription and
regulation, specific organ and cell targeting, and/or photon energy conversion have …

To overcome the current limitations of chemodynamic therapy (CDT), a Mo2C‐derived
polyoxometalate (POM) is readily synthesized as a new CDT agent. It permits synergistic …

Tumor hypoxia has proven to be the major bottleneck of photodynamic therapy (PDT) to
clinical transformation. Different from traditional O2 delivery approaches, here we describe …

Chitosan microparticles are frequently used for the encapsulation of ingredients, owing to
their pH-responsive, renewable, biocompatible and antimicrobial properties. Herein, pH …

Photodynamic therapy (PDT), a non-invasive therapeutic modality, has received increasing
attention owing to its high selectivity and limited side effects. Although significant clinical …

In treatment of hypoxic tumors, oxygen‐dependent photodynamic therapy (PDT) is
considerably limited. Herein, a new bimetallic and biphasic Rh‐based core–shell …

Abstract Recently, near-infrared (NIR) absorbing photothermal therapy (PTT) agents, which
usually apply for deep-tissue cancer treatment, has gained increasing attention due to deep …